Cite
HARVARD Citation
van Brummelen, E. et al. (2021). Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer. Oncologist. pp. 290-e545. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
van Brummelen, E. et al. (2021). Phase I Study of Afatinib and Selumetinib in Patients with KRAS‐Mutated Colorectal, Non‐Small Cell Lung, and Pancreatic Cancer. Oncologist. pp. 290-e545. [Online].